VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization
ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPopulation Health Research Institute
About this trial
The clinic visits (intervention) will continue for 90 days, which represents the follow-up period for the primary medication and health status outcomes. The co-primary clinical outcomes will be obtained at 180 days.
Eligibility criteria
Qualifiers
Are being discharged after hospitalization or urgent visit for HF as
a primary diagnosis or
significant complication (prolonging length of stay) of another diagnosis OR Have been referred for an initial consult at a cardiology clinic within 1 week of hospitalization or urgent visit for HF as a primary or secondary diagnosis, as described above.
Have left ventricular ejection fraction (LVEF) < 50% within the preceding 3 months.
Disqualifiers
Died or left hospital before medically advised hospital discharge
Unable to self-assess or communicate symptoms (e.g. clinically evident dementia)
Unable to engage with digital health technology or follow up
Severe valve disease
Trial design
Treatments tested in this trial
- Virtual HF Care
- Routine HF Care
Treatment groups
891 Participants
are divided into 2 treatment groupsSponsors and collaborators
Population Health Research Institute
Lead sponsor
Hamilton Health Sciences Corporation
Collaborator
McMaster University
Collaborator
Source ClinicalTrials.gov